FLT3 and acute myeloid leukemia: The ITD mutation of FLT3, observed in a subpopulation of AML patients, leads to its constitutive activation as well as the activation of its downstream signaling, such as PI3K/AKT, MAPK/ERK, and STAT5, which is associated with adverse prognosis [16,17].